We have located links that may give you full text access.
Human sex hormone-binding globulin does not provide metabolic protection against diet-induced obesity and dysglycemia in mice.
Endocrine Connections 2018 January
BACKGROUND: Sex hormone-binding globulin (SHBG) is the main transporter of sex hormones in most vertebrates. Low SHBG levels have been linked to increased risk for diabetes and metabolic syndrome. Polymorphisms of the SHBG gene linked to low SHBG protein levels also strongly predicted increased risk of type 2 diabetes, thus raising the possibility that SHBG may play a role in the pathogenesis of insulin resistance and diabetes.
AIM: To examine whether expression of human SHBG in mice may ameliorate the development of diabetes and metabolic syndrome in response to a high-fat diet (HFD).
METHODS: Transgene mice expressing a human SHBG transgene ( SHBG+ ) ( N = 10/11; males/females) and their wild type littermates ( N = 12/8; males/females) were fed HFD for 4.5 months.
RESULTS: HFD induced comparable obesity in control and SHBG+ mice. Male transgenes had higher muscle mass after 2-3.5 months HFD (0.43 ± 0.028 ( n = 4) vs 0.38 ± 0.053 g ( n = 7), P = 0.05). Fasting blood glucose, as well as insulin or HOMA-IR, was not different in transgenic vs wild-type males after 4-5 months HFD. Female transgenes had higher fasting glucose (152 ± 29 ( n = 7) vs 115 ± 27 mg/dL, P = 0.01 ( n = 8)), but mean insulin and HOMA-IR were not different. Likewise, insulin tolerance test and intra-peritoneal glucose tolerance test (GTT) were not different. Finally, SHBG + mice were not different from controls in terms of liver enzymes, serum triglyceride levels and blood pressure.
CONCLUSION: In mice with diet-induced obesity, human SHBG did not protect against development of obesity or dysglycemia.
AIM: To examine whether expression of human SHBG in mice may ameliorate the development of diabetes and metabolic syndrome in response to a high-fat diet (HFD).
METHODS: Transgene mice expressing a human SHBG transgene ( SHBG+ ) ( N = 10/11; males/females) and their wild type littermates ( N = 12/8; males/females) were fed HFD for 4.5 months.
RESULTS: HFD induced comparable obesity in control and SHBG+ mice. Male transgenes had higher muscle mass after 2-3.5 months HFD (0.43 ± 0.028 ( n = 4) vs 0.38 ± 0.053 g ( n = 7), P = 0.05). Fasting blood glucose, as well as insulin or HOMA-IR, was not different in transgenic vs wild-type males after 4-5 months HFD. Female transgenes had higher fasting glucose (152 ± 29 ( n = 7) vs 115 ± 27 mg/dL, P = 0.01 ( n = 8)), but mean insulin and HOMA-IR were not different. Likewise, insulin tolerance test and intra-peritoneal glucose tolerance test (GTT) were not different. Finally, SHBG + mice were not different from controls in terms of liver enzymes, serum triglyceride levels and blood pressure.
CONCLUSION: In mice with diet-induced obesity, human SHBG did not protect against development of obesity or dysglycemia.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app